Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside.

Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside.

Item
http://www.wikidata.org/entity/Q38542778
Molecular chess? Hallmarks of anti-cancer drug resistanceDual modulation of MCL-1 and mTOR determines the response to sunitinib.Rapamycin enhances the anti-angiogenesis and anti-proliferation ability of YM155 in oral squamous cell carcinoma.MicroRNA-16-5p overexpression suppresses proliferation and invasion as well as triggers apoptosis by targeting VEGFA expression in breast carcinoma.From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib.Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.The yin yang of sunitinib: One drug, two doses, and multiple outcomes.
P2860

Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside.

Item
http://www.wikidata.org/entity/Q38542778
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dual inhibition of mTOR pathwa ...... plasms: from bench to bedside.
@en
type
label
Dual inhibition of mTOR pathwa ...... plasms: from bench to bedside.
@en
prefLabel
Dual inhibition of mTOR pathwa ...... plasms: from bench to bedside.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Dual inhibition of mTOR pathwa ...... oplasms: from bench to bedside
@en
P2093
P304
P31
P356
10.1016/J.CTRV.2015.06.008
P433
P478
P50
P577
P698